Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines

Key concepts in management of vulvar cancer

(2014) Susan Zweizig et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Large contribution of human papillomavirus in vaginal neoplastic lesions: A worldwide study in 597 samples

(2014) L. Alemany et al.   EUROPEAN JOURNAL OF CANCER

Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: A population-based study

(2014) Noori Akhtar-Danesh et al.   GYNECOLOGIC ONCOLOGY

Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma

(2014) Eva Herweijer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Correlates of human papillomavirus vaccine series completion among young adult female initiators

(2014) Mahbubur Rahman et al.   Human Vaccines & Immunotherapeutics

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

(2014) Paulo S Naud et al.   Human Vaccines & Immunotherapeutics

Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time

(2013) J. Alejandro Rauh-Hain et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia

(2013) Camille C. Gunderson et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

(2013) Silvia de Sanjosé et al.   EUROPEAN JOURNAL OF CANCER

“HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination

(2013) Maggie Hendry et al.   VACCINE

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

(2013) H. Ali et al.   BMJ-British Medical Journal

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

(2012) S. N. Tabrizi et al.   JOURNAL OF INFECTIOUS DISEASES

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

(2012) Beatriz Serrano et al.   Infectious Agents and Cancer

Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile

(2011) Nathalie Garçon et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

(2010) Maura L. Gillison et al.   CANCER

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

(2009) Cosette M. Wheeler et al.   JOURNAL OF INFECTIOUS DISEASES

Outcomes After Diagnosis of Vaginal Intraepithelial Neoplasia

(2009) L. Stewart Massad   Journal of Lower Genital Tract Disease

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis

(2008) Hugo De Vuyst et al.   INTERNATIONAL JOURNAL OF CANCER